Homepage

COVID-19 TESTING

AXIM Biotechnologies has developed the first rapid (10-minute) point-of-care test that measures the concentration of neutralizing antibodies to COVID-19.

CLINICAL THERAPEUTICS

AXIM’s clinical therapeutic research focuses around an enzyme called “QSOX1” where the company hopes to bring a novel oncology drug to market 

CANCER DIAGNOSTICS

AXIM is in development of various “point-of-care” diagnostic testing products designed for the early detection of cancer

CANCER DIAGNOSTICS

AXIM is in development of various “point-of-care” diagnostic testing products designed for the early detection of cancer

the Latest On Our Research

Founded in 2014, AXIM® Biotechnologies, Inc. (AXIM) is a vertically integrated research and development company focused on changing diagnosis and treatment for oncology and SARS-CoV-2 (COVID-19). AXIM’s NeuCovix is the first rapid diagnostic test measuring levels of functional neutralizing antibodies that are believed to prevent SARS-CoV-2 from entering the host cells. Additionally, the Company is developing rapid diagnostic tests for the early detection of cancer and proprietary small molecules drugs to treat cancer and block metastasis.

Tauriga Sciences, Inc. Generates Record Monthly E-Commerce Sales for the Month of July 2020
The Company Has Reported Its 5thConsecutive Month of Record Results From Its Highest Margin E-Commerce Business Segment NEW YORK, NY,[...]
Tauriga Sciences, Inc. Receives Notice of Allowance from the European Union Intellectual Property Office – Registering its Trademark for Tauri-Gummies
NEW YORK, NY, Aug. 03, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”),[...]
Tauriga Sciences, Inc. Now Pre-Selling Its Rainbow Deluxe Sampler Pack Exclusively on Its E-Commerce Website
Each Rainbow Deluxe Sampler Pack Contains One Blister Pack of Each of the Six Distinct Tauri-Gum™ Flavors/Versions  NEW YORK, NY, July[...]
Aegea Biotechnologies, Inc. and Tauriga Sciences Inc. Announce Progress on the Development of Rapid, Lateral Flow Point-of-Care COVID-19 Diagnostic Test
Additionally—Initial Prototypes of the Portable, Disposable Devices for the Lateral Flow COVID-19 Test Have Been Produced NEW YORK, NY and[...]
Tauriga Sciences, Inc. Expands its E-Commerce Product Offerings to Include CBD Infused Skin Care Products & Face Masks
NEW YORK, NY, July 23, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”),[...]
Tauriga Sciences, Inc. Preparing for Multiple Major Upcoming Product Launches During This Current Operating Quarter
Additionally, the Company Continues to Realize Material Progress with Respect to its Two Ongoing Biotechnology Initiatives NEW YORK, NY, July[...]